Samsara Vision SING IMT

The med-tech company Samsara Vision is engaged in the research, development and manufacture of ophthalmic implants. These are designed to significantly improve the vision and quality of life of people with retinal diseases that cannot be treated. 
Samsara Vision has developed a miniature implant designed to improve the visual acuity and field of vision of patients with late-stage age-related macular degeneration (AMD). The first generation of the implant is already being used by more than 600 patients. The advanced SING-IMT™ is implanted in a short ophthalmic procedure and immediately increases the vision of affected individuals. The effects of the "blind spot" of macular degeneration are thus minimized and patients can once again perceive images that may have previously been unrecognizable due to their disease. 

Disclaimer: The SING IMT is not FDA approved.